Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction
GJ Kauffman,
TS Boyne,
DD Watson,
WH Smith,
and
GA Beller
Cardiovascular Division, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
OBJECTIVES: We prospectively compared myocardial uptake of thallium-201 (201Tl) at rest with rest technetium-99m (99mTc) sestamibi uptake in the same patients, using quantitative singlephoton emission computed tomography (SPECT). BACKGROUND: Because of only slightly delayed redistribution, 99mTc-sestamibi uptake at rest may be less than 201Tl uptake, thereby underestimating the extent of viability. METHODS: Twenty patients (2.25 stenoses per patient) with a mean left ventricular ejection fraction of 33 +/- 2% underwent early and 3-h delayed rest 201Tl SPECT, rest 99mTc-sestamibi SPECT and two-dimensional echocardiography. RESULTS: The 280 scan segments were classified as either a normal, mild reduction in viability, defined as delayed 201Tl uptake < or = 75% and > or = 5%, or a severe reduction in viability, defined as delayed 201Tl uptake < 50%. Mild and severe defects were further classified as fixed or having rest 201Tl redistribution. Comparisons by patients were made using repeated measures analysis of variance and Dunnett's multiple comparisons test to compare 99mTc-sestamibi with initial rest 201Tl and delayed 201Tl uptake. Twenty patients had at least one mild fixed defect (95 total segments). The average percent uptake in these defects for initial 201Tl, delayed 201Tl and 99mTc-sestamibi was 62.5 +/- 2.7%, 63.1 +/- 7.1% and 67.3 +/- 9.7%, respectively (p = NS). Twelve patients (27 segments) had mild redistribution defects on serial rest 201Tl imaging. The average percent uptake was 61.6 +/- 5.2% for initial 201Tl, 67.0 +/- 9.1% for delayed 201Tl and 67.7 +/- 12.4% for 99mTc-sestamibi defects. Technetium-99m sestamibi uptake was not significantly different than that for delayed 201Tl but was significantly greater than initial 201Tl uptake. Seventeen patients (52 segments) had severe fixed 201Tl defects. The average percent uptake was 38.9 +/- 7.3% for initial 201Tl, 38.3 +/- 12.2% for delayed 201Tl and 42.7 +/- 14.2% for 99mTc-sestamibi defects in these patients (p = NS). Ten patients (19 segments) had severe redistribution defects on rest 201Tl imaging. The average percent uptake was 37.0 +/- 8.5% for initial 201Tl, 42.9 +/- 8.6% for delayed 201Tl and 44.5 +/- 11.3% for 99mTc-sestamibi defects. As was seen for mild 201Tl redistribution defects, 99mTc-sestamibi uptake was significantly higher than initial 201Tl uptake, but not significantly different than delayed 201Tl uptake in these severe defects. CONCLUSIONS: Technetium-99m sestamibi uptake after injection at rest is comparable to 201Tl uptake after injection at rest in patients with severe coronary artery disease and left ventricular dysfunction, suggesting comparable worth for viability assessment.
This article has been cited by other articles:
|
|
|
|
 
S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns
Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology
Eur. Heart J.,
May 2, 2004;
25(10):
815 - 836.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Fleischmann, P. Koepfli, M. Namdar, C. A. Wyss, R. Jenni, and P. A. Kaufmann
Gated 99mTc-Tetrofosmin SPECT for Discriminating Infarct from Artifact in Fixed Myocardial Perfusion Defects
J. Nucl. Med.,
May 1, 2004;
45(5):
754 - 759.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Liu, G. A. Kastis, G. D. Stevenson, H. H. Barrett, L. R. Furenlid, M. A. Kupinski, D. D. Patton, and D. W. Wilson
Quantitative Analysis of Acute Myocardial Infarct in Rat Hearts with Ischemia-Reperfusion Using a High-Resolution Stationary SPECT System
J. Nucl. Med.,
July 1, 2002;
43(7):
933 - 939.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C Anagnostopoulos, M Y Henein, and S R Underwood
Non-invasive investigations: Ischaemic heart disease
Br. Med. Bull.,
October 1, 2001;
59(1):
29 - 44.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.-M. J. Siebelink, P. K. Blanksma, H. J. G. M. Crijns, J. J. Bax, A. J. van Boven, T. Kingma, D. A. Piers, J. Pruim, P. L. Jager, W. Vaalburg, et al.
No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: A prospective, randomized comparison of patients with suspicion of jeopardized myocardium
J. Am. Coll. Cardiol.,
January 1, 2001;
37(1):
81 - 88.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. A. Beller and B. L. Zaret
Contributions of Nuclear Cardiology to Diagnosis and Prognosis of Patients With Coronary Artery Disease
Circulation,
March 28, 2000;
101(12):
1465 - 1478.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. G. Gunning, C. Anagnostopoulos, C. J. Knight, J. Pepper, E. D. Burman, G. Davies, K. M. Fox, D. J. Pennell, P. J. Ell, and S. R. Underwood
Comparison of 201Tl, 99mTc-Tetrofosmin, and Dobutamine Magnetic Resonance Imaging for Identifying Hibernating Myocardium
Circulation,
November 3, 1998;
98(18):
1869 - 1874.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. D. Trachiotis, W. S. Weintraub, T. S. Johnston, E. L. Jones, R. A. Guyton, and J. M. Craver
Coronary artery bypass grafting in patients with advanced left ventricular dysfunction
Ann. Thorac. Surg.,
November 1, 1998;
66(5):
1632 - 1639.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Matsunari, G. Boning, S. I. Ziegler, S. G. Nekolla, J. C. Stollfuss, I. Kosa, E. P. Ficaro, and M. Schwaiger
Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using 18F-fluorodeoxyglucose
J. Am. Coll. Cardiol.,
October 1, 1998;
32(4):
927 - 935.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Schneider, E. Voth, S. Gawlich, F. M. Baer, M. Horst, H. Schicha, E. Erdmann, and U. Sechtem
Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after q wave myocardial infarction: importance of infarct location adjusted thresholds
J. Am. Coll. Cardiol.,
September 1, 1998;
32(3):
648 - 654.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. A. Dakik, J. F. Howell, G. M. Lawrie, R. Espada, D. G. Weilbaecher, Z.-X. He, J. J. Mahmarian, and M. S. Verani
Assessment of Myocardial Viability With 99mTc-Sestamibi Tomography Before Coronary Bypass Graft Surgery : Correlation With Histopathology and Postoperative Improvement in Cardiac Function
Circulation,
November 4, 1997;
96(9):
2892 - 2898.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
G. Vanzetto, D. A. Calnon, M. Ruiz, D. D. Watson, R. Pasqualini, G. A. Beller, and D. K. Glover
Myocardial Uptake and Redistribution of 99mTc-N-NOET in Dogs With Either Sustained Coronary Low Flow or Transient Coronary Occlusion : Comparison With 201Tl and Myocardial Blood Flow
Circulation,
October 7, 1997;
96(7):
2325 - 2331.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
R. O. Bonow
Identification of Viable Myocardium
Circulation,
December 1, 1996;
94(11):
2674 - 2680.
[Full Text]
|
|
|
|
|
|
|
Assessing Myocardium: Thallium or Sestamibi?
Journal Watch Cardiology,
September 1, 1996;
1996(901):
12 - 12.
[Full Text]
|
|
|
|
